Condition
Prostatic Neoplasm clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Prostatic Neoplasm clinical trials that are recruiting, at sites in 6 countries (most in United States (2), Italy (2), South Korea (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 6Countries
Newest Prostatic Neoplasm clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using AI to help find prostate cancer on MRI | — | Cleveland, Ohio | Recruiting | Jul 25, 2025 |
| Understanding how obesity-related factors influence prostate cancer progression | — | Milan | Recruiting | Mar 5, 2024 |
| Evaluating Ifosfamide/Mesna for Advanced Prostate Cancer | — | Seoul | Recruiting | Feb 1, 2024 |
| Using augmented reality to improve prostate cancer surgery outcomes | — | Milan | Recruiting | Sep 29, 2023 |
| Understanding factors affecting prostate cancer progression | — | Rennes, Ille-et-Vilaine and 1 other locations | Recruiting | Sep 21, 2023 |
| Combination of trastuzumab and pertuzumab for treating cancers with HER2 mutations | Phase 2/3 | Belfast and 26 other locations | Recruiting | Mar 28, 2023 |
| Evaluating genetic risk and screening for prostate cancer | — | Boston, Massachusetts | Recruiting | Nov 22, 2021 |
All recruiting trials (7)
-
Using AI to help find prostate cancer on MRI
This study tests whether an AI software can help doctors find suspicious lesions on prostate MRI in men aged 55–80 who are having a pre-biopsy MRI and planned prostate biopsy.
-
Understanding how obesity-related factors influence prostate cancer progression
This study looks at how being overweight or obese affects prostate cancer by checking certain enzymes and immune cells in tumor samples from patients with different body weights.
-
Evaluating Ifosfamide/Mesna for Advanced Prostate Cancer
This study is testing whether a combination of ifosfamide and mesna can help people with advanced prostate cancer who haven't had success with other treatments.
-
Using augmented reality to improve prostate cancer surgery outcomes
This study is testing whether using augmented reality during prostate cancer surgery can lead to better outcomes and help preserve erectile function compared to standard surgery methods.
-
Understanding factors affecting prostate cancer progression
This study is trying to find out what factors affect how prostate cancer grows in different people to help improve treatment and prevention for those at higher risk.
-
Combination of trastuzumab and pertuzumab for treating cancers with HER2 mutations
This study is testing if a combination of two cancer drugs, trastuzumab and pertuzumab, can help adults and young people with cancers that have HER2 mutations or amplifications.
-
Evaluating genetic risk and screening for prostate cancer
This study is testing if prostate MRIs can help men at high genetic risk for prostate cancer find aggressive forms of the disease earlier.
Related topics
Quick answers
How many Prostatic Neoplasm clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (2 trials), Italy (2 trials), South Korea (1 trial), France (1 trial), Guadeloupe (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.